Zhishi Xiebai Guizhi Decoction for coronary heart disease: A systematic review and meta-analysis

Ming Li,Shengqiang Song,Yuanhang Rong,Di Wu,Yongtian Yin
DOI: https://doi.org/10.1097/md.0000000000036588
IF: 1.6
2024-01-20
Medicine
Abstract:CVD is one of the leading causes of death and disability in human beings. Since 1990, the number of CVD deaths has increased steadily from 12.1 million to 18.6 million in 2019. [ 1 ] CHD makes up almost one-third of the global CVD burden. [ 2 ] CHD is caused by coronary artery stenosis or blockage due to coronary atherosclerosis, resulting in myocardial ischemia,hypoxia, and even necrosis. Patients can present with varying degrees of nausea, chest tightness, chest pain and dyspnea, and even death due to cardiac arrest. [ 3 ] As a result of the increasing morbidity and mortality, CHD has become an important global public health problem. In recent years, the COVID-19 pandemic has directly or indirectly increased the burden of CVD, putting those who suffer from CHD at a higher risk of dying. [ 4 ]
medicine, general & internal
What problem does this paper attempt to address?